Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis

Molecular Medicine Reports

Volumn 5, Issue 5, 2012, Pages 1256-1260

  Zhou, Liping ^a   Luan, Hong ^a   Liu, Qingpeng ^a   Jiang, Tingshu ^a   Liang, Hongyuan ^a   Dong, Xihua ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Lung cancer cells; Sinomenine

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SINOMENINE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LUNG CANCER; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHINANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84863261665     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.798     Document Type: Article

References (26)

1. Wong LC and Wu LT: History of Chinese Medicine. National Quarantine Service, Shanghai, 1936 (In Chinese).
2. Yamasaki H: Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama 30: 1-20, 1976.
3. Kong QF and Li J: New study progress of sinomenine. Zhongguo Zhong Yao Za Zhi 30: 1573-1576, 2005 (In Chinese).
4. Wang Y, Zhou L and Li R: Study progress in Sinomenium acutum (Thunb.) Rehd. et Wils. Zhong Yao Cai 25: 209-211, 2002 (In Chinese).
5. Kok T, Yue P, Mak N, Fan T, Liu L and Wong R: The anti-angiogenic effect of sinomenine. Angiogenesis 8: 3-12, 2005. (Pubitemid 41223834)
6. Qian L, Xu Z, Zhang W, Wilson B, Hong JS and Flood PM: Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflammation 4: 23-37, 2007.
7. Xu M, Liu L, Qi C, Deng B and Cai X: Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Planta Med 74: 1423-1429, 2008.
8. Vieregge B, Resch K and Kaever V: Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid. Planta Med 65: 80-82, 1999. (Pubitemid 29077437)
9. Liu L, Resch K and Kaever V: Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int J Immunopharmacol 16: 685-691, 1994. (Pubitemid 24238693)
10. Kondo Y, Takano F, Yoshida K and Hojo H: Protection by sinomenine against endotoxin-induced fulminant hepatitis ingalactosamine- sensitized mice. Biochem Pharmacol 48: 1050-1052, 1994. (Pubitemid 24285185)
11. Candinas D, Mark W, Kaever V, Miyatake T, Koyamada N, Hechenleitner P and Hancock WW: Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model. Transplantation 62: 1855-1860, 1996. (Pubitemid 27014551)
12. Jiang TS, Zhou LP, Zhang WL, Qu D, Xu XM, Yang Y and Li S: Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Reports 3: 51-56, 2010.
13. Lee ER, Kim JY, Kang YJ, Ahn JY, Kim JH, Kim BW, Choi HY, Jeong MY and Cho SG: Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis. Biochim Biophys Acta 1763: 958-968, 2006.
14. Cho HS, Chang SH, Chung YS, Shin JY, Park SJ, Lee ES, et al: Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci 10: 23-28, 2009.
15. Meng J, Dai B, Fang B, Bekele BN, Bornmann WG, Sun D, Peng Z, Herbst RS, Papadimitrakopoulou V, Minna JD, et al: Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo. PLoS One 5: e14124, 2010.
16. Szczuka I and Roszkowski-Śliż K: Lung cancer in Poland in 1970-2004. Pneumonol Alergol Pol 76: 19-28, 2008 (In Polish).
17. Yan LC, Bi EG, Lou YT, Wu XD, Liu ZD, Zhou J, Wang Y, Ma Z, Lin GM, Sun SH, et al: Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 391: 1093-1098, 2010.
18. Gong L and Gao Y: Apoptotic derivation of hepatoma carcinoma cell by kukoline. J Chengdu Univ Tradit Chin Med 30: 38-39, 2007 (In Chinese).
19. Li XJ, Yue PY, Ha WY, Wong DY, Tin MM, Wang PX, Wong RN and Liu L: Effect of sinomenine on gene expression of the IL-1 beta-activated human synovial sarcoma. Life Sci 79: 665-673, 2006. (Pubitemid 43927979)
20. Hövelmann S, Beckers TL and Schmidt M: Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells. Br J Cancer 90: 2370-2377, 2004. (Pubitemid 38961902)
21. Fry MJ: Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? Breast Cancer Res 3: 304-312, 2001.
22. Izycka-Swieszewska E, Brzeskwiniewicz M, Wozniak A, Drozynska E, Grajkowska W, Perek D, Balcerska A, Klepacka T and Limon J: EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours. Folia Neuropathol 48: 238-245, 2010.
23. Lin X, Böhle AS, Dohrmann P, Leuschner I, Schulz A, Kremer B and Fändrich F: Overexpression of phosphatidylinositol 3-kinase in human lung cancer. Langenbecks Arch Surg 386: 293-301, 2001 (Pubitemid 32702759)
24. Perkinton MS, Ip JK, Wood GL, Crossthwaite AJ and Williams RJ: Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones. J Neurochem 80: 239-254, 2002. (Pubitemid 34809369)
25. He X, Wang J, Guo Z, Liu Q, Chen T, Wang X and Cao X: Requirement for ERK activation in sinomenine-induced apoptosis of macrophages. Immunol Lett 98: 91-96, 2005. (Pubitemid 40409823)
26. Lu ZJ, Zhou Y, Song Q, Qin Z, Zhang H, Zhou YJ, Gou LT, Yang JL and Luo F: Periplocin inhibits growth of lung cancer in vitro and in vivo by blocking AKT/ERK signaling pathways. Cell Physiol Biochem 26: 609-618, 2010.